Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses

Cell

Volumn 93, Issue 3, 1998, Pages 373-383

  Rodig, Scott J ^a   Meraz, Marco A ^a   White, J Michael ^a   Lampe, Pat A ^a   Riley, Joan K ^a   Arthur, Cora D ^a   King, Kathleen L ^b   Sheehan, Kathleen C F ^a   Yin, Li ^a   Pennica, Diane ^b   Johnson Jr , Eugene M ^a   Schreiber, Robert D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EMBRYO; GENE DISRUPTION; GENE MUTATION; GENE TARGETING; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALIA; JANUS;

EID: 0032076183     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81166-6     Document Type: Article

References (39)

1. Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R., and Weissman, I.L. (1997). Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89, 1033-1041.
2. Bach, E.A., Aguet, M., and Schreiber, R.D. (1997).The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563-591.
3. Celada, A., Gray, P.W., Rinderknecht, E., and Schreiber, R.D. (1984). Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med. 160, 55-74.
4. Darnell, J.E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
5. Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
6. Dechiara, T.M., Vejsada, R., Poueymirou, W.T., Acheson, A., Suri, C., Conover, J.C., Friedman, B., McClain, J., Pan, L., Stahl, N., et al. (1995). Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83, 313-322.
7. Dighe, A.S., Campbell, D., Hsieh, C.-S., Clarke, S., Greaves, D.R., Gordon, S., Murphy, K.M., and Schreiber, R.D. (1995). Tissue specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3, 657-666.
8. Durbin, J.E., Hackenmiller, R., Simon, M.C., and Levy, D.E. (1996). Targeted disruption of the mouse Stat 1 gene results in compromised innate immunity to viral infection. Cell 84, 443-450.
9. Greenlund, A.C., Farrar, M.A., Viviano, B.L., and Schreiber, R.D. (1994). Ligand induced IFNγ receptor phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13, 1591-1600.
10. Gribaudo, G., Cofano, F., Prat, M., Baiocchi, C., Cavallo, G., and Landolfo, S. (1985). Natural murine interferon-gamma: evidence for post-translational proteolytic processing. J. Biol. Chem. 260, 9936-9940.
11. Guschin, D., Rogers, N., Briscoe, J., Witthuhn, B., Watling, D., Horn, F., Pellegrini, S., Yasukawa, K., Heinrich, P., Stark, G.R., Ihle, J.N., and Kerr, I.M. (1995). A major role for the protein tyrosine kinase Jak1 in the Jak/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14, 1421-1429.
12. Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D., and Hayakawa, K. (1991). Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213-1225.
13. Ho, A.S.-Y., Wei, S.H.-Y., Mui, A.L.-F., Miyajima, A., and Moore, K.W. (1995). Functional regions of the mouse IL-10 receptor cytoplasmic domain. Mol. Cell. Biol. 15, 5043-5053.
14. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R., and Aguet, M. (1993). Immune response in mice that lack the interferon-γ receptor. Science 259, 1742-1745.
15. Ihle, J.N., Witthuhn, B.A., Quelle, F.W., Yamamoto, K., and Silvennoinen, O. (1995). Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369-398.
16. King, K.L., Lai, J., Winer, J., Luis, E., Yen, R., Hooley, J., Williams, P.M., and Mather, J.P. (1996). Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro. Endocrine 5, 85-93.
17. Kishimoto, T., Akira, S., Narazaki, M., and Taga, T. (1995). Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
18. Kouro, T., Kikuchi, Y., Kanazawa, H., Hirokawa, K., Harada, N., Shiiba, M., Wakao, H., Takaki, S., and Takatsu, K. (1996). Critical proline residues in the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5. Int. Immunol. 8, 237-245.
19. Leonard, W.J., Shores, E.W., and Love, P.E. (1995). Role of the common cytokine receptor γ chain in cytokine signaling and lymphoid development. Immunol. Rev. 148, 97-114.
20. Li, M., Sendtner, M., and Smith, A. (1995). Essential function of LIF receptor in motor neurons. Nature 378, 724-727.
21. Meraz, M.A., White, J.M., Sheehan, K.C.F., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell, D., et al. (1996). Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the Jak-STAT signaling pathway. Cell 84, 431-442.
22. Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A.G., Barbier, G., Witthuhn, B.A., Schindler, C., et al. (1993). The protein tyrosine kinase JAK1 complements a mutant cell line defective in the interferon-α/γ and -γ signal transduction pathways. Nature 366, 129-135.
23. Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., and Pfeffer, K. (1998). Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93, this issue, 397-409.
24. Nicholson, A.E., Oates, A.C., Harpus, A.G., Ziemiecki, A., Wilks, A.F. and Layton, J.E. (1994). Tyrosine kinase Jak1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc. Natl. Acad. Sci. USA 91, 2985-2988.
25. Nosaka, T., van Deursen, J.M.A., Tripp, R.A., Thierfelder, W.E., Witthuhn, B.A., McMickle, A.P., Doherty, P.C., Grosveld, G.C., and Ihle, J.N. (1995). Defective lymphoid development in mice lacking Jak3. Science 270, 800-802.
26. O'Shea, J.J. (1997). Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7, 1-11.
27. Parganas, E., Wang, D., Stravopodis, D., Topham, D.J., Marine, J.-C., Teglund, S., Vanin, E., Bodner, S., Colamonici, O.R., van Deursen, J.M., Grosveld, G., and Ihle, J.N. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, this issue, 385-395.
28. Park, S.Y., Saijo, K., Takahashi, T., Osawa, M., Arase, H., Hirayama, N., Miyake, K., Nakauchi, H., Shirasawa, T., and Saito, T. (1995). Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3, 771-782.
29. Peschon, J.J., Morrissay, P.J., Grabstein, K.H., Ramsdell, F.J., Maraskovsky, E., Gliniak, B.C., Park, L.S., Ziegler, S.F., Williams, D.E., Ware, C.B., et al. (1994). Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960.
30. Russell, S.M., Tayebi, N., Nakajima, H., Riedy, M.C., Roberts, J.L., Aman, M.J., Migone, T., Noguchi, M., Markert, M.L., Buckley, R.H., O'Shea, J.J., and Leonard, W.J. (1995). Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797-800.
31. Stahl, N., Boulton, T.G., Farruggella, T., Ip, N.Y., Davis, S., Witthuhn, B.A., Quelle, F.W., Silvennoinen, O., Barbiere, G., Pellegrini, S., Ihle, J.N., and Yancopoulos, G.D. (1994). Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263, 92-95.
32. Suda, T., Okada, S., Suda, J., Miura, Y., Ito, Y., Sudo, T., Hayashi, S., Nishikawa, S., and Nakauchi, H. (1989). A stimulatory effect of recombinant murine interleukin-7 (IL-7) on B-cell colony formation and an inhibitory effect of IL-1α. Blood 74, 1936-1941.
33. Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.M., and Berg, L.J. (1995). Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797.
34. Todaro, G.J., and Green, H. (1963). Quantitative studies of the growth of mouse embryo cells in culture and their development in established lines. J. Cell Biol. 17, 299-313.
35. Velazquez, L., Fellous, M., Stark, G.R., and Pellegrini, S. (1992). A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70, 313-322.
36. von Freeden-Jeffry, U., Vieira, P., Lucian, L.A., McNeil, T., Burdach, S.E., and Murray, R. (1995). Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526.
37. Ware, C.B., Horowitz, M.C., Renshaw, B.R., Hunt, J.S., Liggit, D., Koblar, S.A., Gliniak, B.C., McKenna, H.J., Papayannopoulou, T., Thoma, B., et al. (1995). Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural, and metabolic defects and results in perinatal death. Development 121, 1283-1299.
38. Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B.A., Quelle, F.W., Rogers, N.C., Schindler, C., Stark, G.R., Ihle, J.N. and Kerr, I.M. (1993). Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 366, 166-170.
39. Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996). Targeted disruption of gp130, a common signal transducer for IL-6-family cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93, 407-411.